StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
72
Publishing Date
2022 - 03 - 17
1
2022 - 03 - 16
1
2022 - 03 - 15
1
2022 - 03 - 09
1
2022 - 02 - 24
2
2022 - 02 - 23
1
2022 - 02 - 10
1
2022 - 02 - 09
1
2022 - 02 - 03
2
2021 - 11 - 11
1
2021 - 11 - 09
3
2021 - 11 - 08
1
2021 - 11 - 04
4
2021 - 11 - 01
1
2021 - 10 - 28
2
2021 - 10 - 27
2
2021 - 10 - 26
1
2021 - 10 - 14
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 08
1
2021 - 08 - 27
1
2021 - 08 - 12
1
2021 - 08 - 09
2
2021 - 08 - 06
2
2021 - 08 - 05
2
2021 - 08 - 03
1
2021 - 08 - 02
1
2021 - 07 - 29
1
2021 - 07 - 28
1
2021 - 07 - 16
1
2021 - 07 - 13
1
2021 - 05 - 20
1
2021 - 05 - 13
2
2021 - 05 - 10
2
2021 - 05 - 06
2
2021 - 05 - 04
2
2021 - 05 - 03
2
2021 - 04 - 29
3
2021 - 04 - 13
1
2021 - 03 - 30
1
2021 - 03 - 23
1
2021 - 03 - 18
2
2021 - 03 - 17
1
2021 - 03 - 16
1
2021 - 03 - 11
1
2021 - 03 - 10
1
2021 - 03 - 02
1
2021 - 02 - 25
2
2015 - 02 - 26
1
2014 - 11 - 10
1
Sector
Communications
1
Finance
1
Health technology
72
Retail trade
1
Tags
Acquisition
87
Alliances
89
America
64
Antibody
65
Approval
97
Biopharma
102
Biotech
87
Biotechnology
120
Business
80
Cancer
215
Children
68
Clinical-trials-phase-ii
51
Clinical-trials-phase-iii
80
Collaboration
102
Companies
59
Conference
58
Covid
128
Covid-19
111
Diabetes
60
Disease
179
Drug
240
Dupixent
118
Earnings
96
Europe
92
Events
61
Fda
236
Financial
163
Financial results
72
Genetown
73
Global
356
Growing
56
Growth
325
Health
71
Insulin
54
Iot
56
Market
719
Money
69
N/a
2816
News
122
People
224
Pharm-country
54
Pharma
191
Pharmaceutical
143
Positive
103
Potential
67
Regulatory
57
Report
312
Research
265
Results
366
Sanofi
199
Spac
62
Study
86
Technology
68
Therapeutics
342
Therapy
113
Treatment
276
Trial
165
Update
91
Vaccine
258
Year
61
Entities
111, inc.
1
Alnylam pharmaceuticals, inc.
4
Avrobio, inc.
1
Axcella health inc.
1
Bicycle therapeutics plc
1
Biogen inc.
1
Biomarin pharmaceutical inc.
5
Biontech se
8
Boston scientific corporation
1
Bristol-myers squibb company
3
Cellectis s.a.
2
Cogent biosciences, inc.
1
Denali therapeutics inc.
1
Gilead sciences, inc.
2
Hercules capital, inc.
1
Innate pharma s.a.
4
Innate pharma sa
1
Inovio pharmaceuticals, inc.
3
Ionis pharmaceuticals, inc.
2
Johnson & johnson
1
Kymera therapeutics, inc.
4
Lexicon pharmaceuticals, inc.
1
Ligand pharmaceuticals incorporated
3
Lyra therapeutics, inc.
1
Matinas biopharma holdings, inc.
1
Medicinova, inc.
1
Merck & company, inc.
4
Merrimack pharmaceuticals, inc.
2
Mirati therapeutics, inc.
1
Novo nordisk a/s
4
Nurix therapeutics, inc.
3
Orange
1
Prelude therapeutics incorporated
1
Relay therapeutics, inc.
1
Replimune group, inc.
4
Revolution medicines, inc.
1
Sangamo therapeutics, inc.
3
Sanofi
72
Seagen inc.
1
Translate bio, inc.
2
Verastem, inc.
1
Vertex pharmaceuticals incorporated
1
Zealand pharma a/s
1
Symbols
ABBV
12
ABUS
10
ADCT
10
ADMA
12
AGIO
10
AGTC
10
ALBO
12
ALKS
10
ALLO
10
ALNY
13
AMGN
13
APDN
11
API
10
APYX
10
AQN
10
ARVL
22
AVXL
11
BCPC
11
BGNE
12
BMY
17
CPRX
11
DAO
17
DSX
11
DTIL
11
FNCTF
33
FRBA
15
GILD
20
HTGC
15
INCY
13
JNJ
39
LI
12
LLY
42
LXRX
11
MDT
15
MDWD
14
MGIC
11
MPLX
13
MS
22
NEE
13
NEP
13
NERV
11
NKTR
12
NTES
18
NVS
13
OTIC
13
PAYD
12
REGN
11
RGEN
11
SLRX
12
SNY
72
SNYNF
27
SREV
13
TAK
13
TGTX
11
THTX
12
UTHR
13
UXIN
12
VIVE
14
XYF
21
ZLAB
15
Exchanges
Amex
1
Nasdaq
72
Nyse
14
Crawled Date
2022 - 03 - 17
1
2022 - 03 - 16
1
2022 - 03 - 15
1
2022 - 03 - 09
1
2022 - 02 - 25
1
2022 - 02 - 24
1
2022 - 02 - 23
1
2022 - 02 - 10
1
2022 - 02 - 09
1
2022 - 02 - 03
2
2021 - 11 - 11
1
2021 - 11 - 09
3
2021 - 11 - 08
1
2021 - 11 - 05
2
2021 - 11 - 04
2
2021 - 11 - 01
1
2021 - 10 - 28
2
2021 - 10 - 27
2
2021 - 10 - 26
1
2021 - 10 - 14
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 08
1
2021 - 08 - 27
1
2021 - 08 - 12
1
2021 - 08 - 09
2
2021 - 08 - 06
2
2021 - 08 - 05
2
2021 - 08 - 03
1
2021 - 08 - 02
1
2021 - 07 - 29
1
2021 - 07 - 28
1
2021 - 07 - 16
1
2021 - 07 - 13
1
2021 - 05 - 20
1
2021 - 05 - 13
2
2021 - 05 - 10
2
2021 - 05 - 06
2
2021 - 05 - 04
2
2021 - 05 - 03
2
2021 - 04 - 29
3
2021 - 04 - 13
1
2021 - 03 - 30
1
2021 - 03 - 23
1
2021 - 03 - 21
2
2021 - 03 - 18
2
2021 - 03 - 17
1
2021 - 03 - 16
1
2021 - 03 - 11
1
2021 - 03 - 10
1
2021 - 03 - 08
1
2021 - 03 - 02
1
2021 - 02 - 25
1
Crawled Time
01:00
2
02:00
1
06:00
2
07:00
4
08:20
1
09:00
2
11:00
1
12:00
12
12:15
3
12:20
1
12:30
1
13:00
8
13:30
2
14:00
2
14:15
1
14:30
2
15:15
2
17:00
1
18:00
1
19:44
1
20:00
5
21:00
8
22:00
7
22:12
1
23:00
1
Source
investors.biomarin.com
4
www.biospace.com
33
www.globenewswire.com
28
www.inovio.com
2
www.prnewswire.com
5
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Financial results
symbols :
Sny
save search
Innate Pharma Announces Conference Call and Webcast for Full Year 2021 Financial Results
Published:
2022-03-17
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-10.0%
|
O:
-1.62%
H:
0.0%
C:
0.0%
NVO
|
$122.75
-1.43%
0.67%
42K
|
Health Technology
|
17.97%
|
O:
2.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-12.24%
|
O:
0.17%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
-2.49%
-0.42%
0
|
Health Technology
|
-29.0%
|
O:
1.51%
H:
2.38%
C:
2.08%
financial results
conference
results
pharma
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
Published:
2022-03-16
(Crawled : 13:30)
- biospace.com/
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-11.53%
|
O:
0.82%
H:
0.0%
C:
0.0%
BNTX
|
$86.17
-0.27%
-0.24%
2.2K
|
Health Technology
|
-40.59%
|
O:
1.63%
H:
11.55%
C:
11.21%
financial results
report
results
tiona
Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
Published:
2022-03-15
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-9.93%
|
O:
-3.03%
H:
3.21%
C:
3.21%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-8.82%
|
O:
3.07%
H:
0.0%
C:
0.0%
COGT
|
$6.61
1.23%
1.14%
0
|
Health Technology
|
24.48%
|
O:
0.38%
H:
6.38%
C:
3.94%
financial results
bioscience
results
Lyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published:
2022-03-09
(Crawled : 13:00)
- biospace.com/
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-7.11%
|
O:
-0.5%
H:
0.0%
C:
0.0%
BSX
|
$67.765
0.51%
550K
|
Health Technology
|
59.12%
|
O:
-1.29%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-9.54%
|
O:
1.41%
H:
0.0%
C:
0.0%
LYRA
|
$5.39
-0.28%
-0.65%
0
|
Health Technology
|
17.86%
|
O:
-8.93%
H:
1.79%
C:
-2.63%
BIIB
|
$190.59
0.04%
50K
|
Health Technology
|
-2.82%
|
O:
2.65%
H:
1.72%
C:
-1.88%
financial results
therapeutics
report
results
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Published:
2022-02-24
(Crawled : 01:00)
- biospace.com/
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-10.17%
|
O:
0.78%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-13.35%
|
O:
-4.06%
H:
0.0%
C:
0.0%
SGMO
|
$0.4851
-5.99%
-6.33%
25K
|
Health Technology
|
-90.33%
|
O:
-2.04%
H:
0.0%
C:
0.0%
financial results
therapeutics
report
results
Kymera Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides a Business Update
Published:
2022-02-24
(Crawled : 12:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-10.17%
|
O:
0.78%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-13.35%
|
O:
-4.06%
H:
0.0%
C:
0.0%
KYMR
|
$35.12
4.03%
3.98%
0
|
Health Technology
|
-2.34%
|
O:
-2.56%
H:
13.17%
C:
12.27%
financial results
ces
therapeutics
results
BioMarin Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Updates
Published:
2022-02-23
(Crawled : 22:00)
- investors.biomarin.com
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-10.17%
|
O:
0.78%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-13.35%
|
O:
-4.06%
H:
0.0%
C:
0.0%
BMRN
S
|
$90.07
-0.44%
-0.43%
220
|
Health Technology
|
10.39%
|
O:
-12.72%
H:
9.46%
C:
7.4%
financial results
ces
results
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Period Activity
Published:
2022-02-10
(Crawled : 13:30)
- biospace.com/
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-14.73%
|
O:
-0.92%
H:
0.0%
C:
0.0%
IONS
|
$40.81
-0.24%
-0.25%
5
|
Health Technology
|
23.48%
|
O:
0.7%
H:
3.82%
C:
0.78%
ALNY
|
News
|
$145.16
-0.11%
-0.19%
1
|
Health Technology
|
-2.67%
|
O:
-0.66%
H:
6.03%
C:
1.83%
als
financial results
report
results
Ligand to Report Fourth Quarter Financial Results on February 17
Published:
2022-02-09
(Crawled : 20:00)
- biospace.com/
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-13.36%
|
O:
2.73%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-15.09%
|
O:
-0.43%
H:
0.0%
C:
0.0%
LGND
|
$72.52
-8.05%
-8.62%
0
|
Health Technology
|
-36.07%
|
O:
1.07%
H:
1.67%
C:
0.37%
financial results
report
results
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
Published:
2022-02-03
(Crawled : 14:30)
- globenewswire.com
BMY
|
$48.3
0.96%
0.21%
3.3K
|
Health Technology
|
-25.46%
|
O:
0.08%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-12.68%
|
O:
-0.06%
H:
0.0%
C:
0.0%
REPL
|
$7.0
0.43%
19K
|
Health Technology
|
-60.77%
|
O:
-0.33%
H:
4.15%
C:
-0.38%
financial results
report
results
Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results
Published:
2022-02-03
(Crawled : 13:00)
- biospace.com/
MRK
|
$125.23
-0.11%
0.41%
1K
|
Health Technology
|
53.13%
|
O:
-0.27%
H:
0.18%
C:
-3.23%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-12.68%
|
O:
-0.06%
H:
0.0%
C:
0.0%
financial results
ces
results
Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Commercial Launch and Timing for Congenital Hyperinsulinism and Short Bowel Syndrome Phase Three Clinical Studies
Published:
2021-11-11
(Crawled : 14:15)
- globenewswire.com
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-9.34%
|
O:
0.08%
H:
0.0%
C:
0.0%
ZEAL
|
$17.59
1.21%
-4.21%
|
Health Technology
|
-43.36%
|
O:
-2.91%
H:
0.0%
C:
-8.51%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-11.36%
|
O:
0.25%
H:
0.0%
C:
0.0%
financial results
results
insulin
syndros
INOVIO Reports Third Quarter 2021 Financial Results
Published:
2021-11-09
(Crawled : 22:00)
- inovio.com
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-9.84%
|
O:
-0.54%
H:
0.0%
C:
-0.01%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-11.56%
|
O:
0.66%
H:
0.25%
C:
-0.89%
INO
3 d
|
$10.2
-7.86%
-8.32%
0
|
Health Technology
|
44.68%
|
O:
0.86%
H:
6.18%
C:
0.13%
financial results
results
Acerus Reports Fiscal Third Quarter Financial Results
Published:
2021-11-09
(Crawled : 13:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-0.83%
0
|
Communications
|
-0.47%
|
O:
0.66%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-10.89%
|
O:
0.76%
H:
0.0%
C:
0.0%
financial results
results
BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update
Published:
2021-11-09
(Crawled : 12:15)
- biospace.com/
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-10.89%
|
O:
0.76%
H:
0.0%
C:
0.0%
BNTX
|
$86.17
-0.27%
-0.24%
2.2K
|
Health Technology
|
-62.94%
|
O:
8.24%
H:
0.53%
C:
-10.05%
financial results
results
Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights
Published:
2021-11-08
(Crawled : 12:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-9.69%
|
O:
0.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-10.99%
|
O:
-0.12%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
1.4K
|
Health Technology
|
1.44%
|
O:
0.05%
H:
0.0%
C:
0.0%
MTNB
|
$0.19
22K
|
Health Technology
|
-82.41%
|
O:
-2.78%
H:
2.86%
C:
-3.81%
biopharma
financial results
results
Sangamo Therapeutics Reports Recent Business and Clinical Highlights and Third Quarter 2021 Financial Results
Published:
2021-11-04
(Crawled : 02:00)
- biospace.com/
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-12.83%
|
O:
-0.42%
H:
0.0%
C:
0.0%
SGMO
|
$0.4851
-5.99%
-6.33%
25K
|
Health Technology
|
-94.08%
|
O:
7.39%
H:
0.0%
C:
0.0%
financial results
results
Verastem Oncology Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
Published:
2021-11-04
(Crawled : 01:00)
- biospace.com/
VSTM
|
$10.23
-5.63%
-6.38%
0
|
Health Technology
|
258.95%
|
O:
-0.7%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-12.83%
|
O:
-0.42%
H:
0.0%
C:
0.0%
financial results
results
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021
Published:
2021-11-04
(Crawled : 21:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
0
|
Health Technology
|
-9.69%
|
O:
0.0%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-12.46%
|
O:
-1.65%
H:
0.0%
C:
0.0%
RLAY
|
$6.11
-1.61%
-1.47%
0
|
Health Technology
|
-82.93%
|
O:
0.03%
H:
1.35%
C:
-2.39%
CLLS
|
$2.47
15K
|
Health Technology
|
-79.89%
|
O:
-5.54%
H:
7.67%
C:
5.43%
financial results
results
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
Published:
2021-11-04
(Crawled : 13:00)
- globenewswire.com
BMY
|
$48.3
0.96%
0.21%
3.3K
|
Health Technology
|
-17.56%
|
O:
1.37%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
47K
|
Health Technology
|
-12.83%
|
O:
-0.42%
H:
0.0%
C:
0.0%
REPL
|
$7.0
0.43%
19K
|
Health Technology
|
-77.29%
|
O:
4.09%
H:
2.47%
C:
0.85%
financial results
results
← Previous
1
2
3
4
Next →
Gainers vs Losers
61%
39%
Top 10 Gainers
AGBA
|
News
|
$1.4
250.0%
35M
|
Finance
RWOD
|
$12.0
50.06%
3.9M
|
n/a
INDO
|
$4.9
20.1%
2.2M
|
Energy Minerals
NURO
|
$4.32
18.36%
66K
|
Health Technology
HUBC
|
$1.52
17.83%
4.7M
|
n/a
CARV
4
|
$1.77
11.32%
8.5K
|
Finance
BROG
|
$1.23
10.81%
320K
|
Finance
PARA
|
$12.03
9.66%
5.8M
|
Information
ADAP
|
$0.98
9.08%
240K
|
Health Technology
POAI
A
|
$1.25
8.69%
16K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.